Zunyan Dai, Ph.D.

Affiliations: 
2002 Ohio State University, Columbus, Columbus, OH 
Area:
Pathology, Oncology, Genetics
Google:
"Zunyan Dai"

Parents

Sign in to add mentor
Christoph Plass grad student 2002 Ohio State
 (Restriction landmark genomic scanning to identify novel methylated and amplified DNA sequences in human lung cancer.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Johnson AD, Zhang Y, Papp AC, et al. (2008) Polymorphisms affecting gene transcription and mRNA processing in pharmacogenetic candidate genes: detection through allelic expression imbalance in human target tissues. Pharmacogenetics and Genomics. 18: 781-91
Dai Z, Papp AC, Wang D, et al. (2008) Genotyping panel for assessing response to cancer chemotherapy. Bmc Medical Genomics. 1: 24
Smiraglia DJ, Kazhiyur-Mannar R, Oakes CC, et al. (2007) Restriction landmark genomic scanning (RLGS) spot identification by second generation virtual RLGS in multiple genomes with multiple enzyme combinations. Bmc Genomics. 8: 446
Blower PE, Verducci JS, Lin S, et al. (2007) MicroRNA expression profiles for the NCI-60 cancer cell panel. Molecular Cancer Therapeutics. 6: 1483-91
Dai Z, Huang Y, Sadee W, et al. (2007) Chemoinformatics analysis identifies cytotoxic compounds susceptible to chemoresistance mediated by glutathione and cystine/glutamate transport system xc-. Journal of Medicinal Chemistry. 50: 1896-906
Cao X, Fang L, Gibbs S, et al. (2007) Glucose uptake inhibitor sensitizes cancer cells to daunorubicin and overcomes drug resistance in hypoxia. Cancer Chemotherapy and Pharmacology. 59: 495-505
Dai Z, Liu S, Marcucci G, et al. (2006) 5-Aza-2'-deoxycytidine and depsipeptide synergistically induce expression of BIK (BCL2-interacting killer). Biochemical and Biophysical Research Communications. 351: 455-61
Wang Y, Dai Z, Sadee W, et al. (2006) A pharmacoproteomics study of the cancer cell line EKVX using capillary-LC/MS/MS. Molecular Pharmaceutics. 3: 566-78
Dai Z, Barbacioru C, Huang Y, et al. (2006) Prediction of anticancer drug potency from expression of genes involved in growth factor signaling. Pharmaceutical Research. 23: 336-49
Huang Y, Dai Z, Barbacioru C, et al. (2005) Cystine-glutamate transporter SLC7A11 in cancer chemosensitivity and chemoresistance. Cancer Research. 65: 7446-54
See more...